Anselamimab Antibody
Anselamimab is a humanized IgG1κ monoclonal antibody that targets serum amyloid A1 (SAA1) to clear amyloid deposits. It has been investigated in clinical trials for AL amyloidosis and serves as a research tool for studying amyloid clearance mechanisms in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
CAEL101, CAEL-101
Target
Beta Amyloid, Apolipoprotein
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Metabolism Research, Neuroscience
Concentration
5.31 mg/mL
Purity
>95.0% (May vary between batches)
Molecular Weight
144.42 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
